CytoMed Therapeutics Limited
GDTC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,639 | $6,816 | $1,179 | $1,863 |
| Short-Term Investments | $0 | $0 | $0 | $11 |
| Receivables | $14 | $0 | $0 | $0 |
| Inventory | $614 | $514 | $430 | $320 |
| Other Curr. Assets | $126 | $320 | $252 | $239 |
| Total Curr. Assets | $4,394 | $7,651 | $1,862 | $2,433 |
| Property Plant & Equip (Net) | $2,382 | $1,565 | $1,848 | $1,851 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $68 | $9 | $14 | $23 |
| Long-Term Investments | $162 | $148 | $179 | $202 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $366 | $0 | $0 | $0 |
| Total NC Assets | $2,978 | $1,722 | $2,041 | $2,077 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7,372 | $9,373 | $3,903 | $4,510 |
| Liabilities | – | – | – | – |
| Payables | $28 | $19 | $11 | $34 |
| Short-Term Debt | $34 | $31 | $2,795 | $2,005 |
| Tax Payable | $0 | $0 | $1 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $382 | $494 | $303 | $138 |
| Total Curr. Liab. | $444 | $543 | $3,110 | $2,177 |
| LT Debt | $306 | $309 | $355 | $411 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $306 | $309 | $355 | $411 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $23 | $5 | $11 | $17 |
| Total Liabilities | $750 | $852 | $3,465 | $2,588 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $17,422 | $17,974 | $6,654 | $4,856 |
| Retained Earnings | -$10,872 | -$9,344 | -$6,121 | -$3,757 |
| AOCI | $15 | -$109 | -$95 | $823 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $6,565 | $8,521 | $438 | $1,922 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $57 | -$1 | -$1 | -$0 |
| Total Liab. & Tot. Equity | $7,372 | $9,373 | $3,903 | $4,510 |
| Net Debt | -$3,300 | -$6,477 | $1,971 | $553 |